• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于数据驱动的冠状动脉支架内再狭窄降阶代理模型。

Data-driven reduced order surrogate modeling for coronary in-stent restenosis.

机构信息

Institute of Applied Mechanics, RWTH Aachen University, Germany.

Institute of Applied Mechanics, RWTH Aachen University, Germany.

出版信息

Comput Methods Programs Biomed. 2024 Dec;257:108466. doi: 10.1016/j.cmpb.2024.108466. Epub 2024 Oct 25.

DOI:10.1016/j.cmpb.2024.108466
PMID:39488041
Abstract

BACKGROUND

The intricate process of coronary in-stent restenosis (ISR) involves the interplay between different mediators, including platelet-derived growth factor, transforming growth factor-β, extracellular matrix, smooth muscle cells, endothelial cells, and drug elution from the stent. Modeling such complex multiphysics phenomena demands extensive computational resources and time.

METHODS

This paper proposes a novel non-intrusive data-driven reduced order modeling approach for the underlying multiphysics time-dependent parametrized problem. In the offline phase, a 3D convolutional autoencoder, comprising an encoder and decoder, is trained to achieve dimensionality reduction. The encoder condenses the full-order solution into a lower-dimensional latent space, while the decoder facilitates the reconstruction of the full solution from the latent space. To deal with the 5D input datasets (3D geometry + time series + multiple output channels), two ingredients are explored. The first approach incorporates time as an additional parameter and applies 3D convolution on individual time steps, encoding a distinct latent variable for each parameter instance within each time step. The second approach reshapes the 3D geometry into a 2D plane along a less interactive axis and stacks all time steps in the third direction for each parameter instance. This rearrangement generates a larger and complete dataset for one parameter instance, resulting in a singular latent variable across the entire discrete time-series. In both approaches, the multiple outputs are considered automatically in the convolutions. Moreover, Gaussian process regression is applied to establish correlations between the latent variable and the input parameter.

RESULTS

The constitutive model reveals a significant acceleration in neointimal growth between 30-60 days post percutaneous coronary intervention (PCI). The surrogate models applying both approaches exhibit high accuracy in pointwise error, with the first approach showcasing smaller errors across the entire evaluation period for all outputs. The parameter study on drug dosage against ISR rates provides noteworthy insights of neointimal growth, where the nonlinear dependence of ISR rates on the peak drug flux exhibits intriguing periodic patterns. Applying the trained model, the rate of ISR is effectively evaluated, and the optimal parameter range for drug dosage is identified.

CONCLUSION

The demonstrated non-intrusive reduced order surrogate model proves to be a powerful tool for predicting ISR outcomes. Moreover, the proposed method lays the foundation for real-time simulations and optimization of PCI parameters.

摘要

背景

冠状动脉支架内再狭窄(ISR)的复杂过程涉及到不同介质的相互作用,包括血小板衍生生长因子、转化生长因子-β、细胞外基质、平滑肌细胞、内皮细胞和支架洗脱的药物。模拟这种复杂的多物理现象需要大量的计算资源和时间。

方法

本文提出了一种新颖的非侵入式数据驱动的降阶建模方法,用于处理基础的多物理时变参数化问题。在离线阶段,使用 3D 卷积自动编码器(包含编码器和解码器)对全阶解进行训练,以实现降维。编码器将全阶解压缩到低维潜在空间,解码器则从潜在空间重构全阶解。为了处理 5D 输入数据集(3D 几何形状+时间序列+多个输出通道),本文探索了两种方法。第一种方法将时间作为附加参数,对各个时间步进行 3D 卷积,为每个时间步内的每个参数实例编码一个独特的潜在变量。第二种方法将 3D 几何形状沿着交互性较小的轴展平到 2D 平面,并在第三个方向上堆叠每个参数实例的所有时间步。这种重排为每个参数实例生成了一个更大、更完整的数据集,从而在整个离散时间序列中产生了一个单一的潜在变量。在这两种方法中,卷积自动编码器自动考虑多个输出。此外,还应用了高斯过程回归来建立潜在变量和输入参数之间的相关性。

结果

本构模型揭示了经皮冠状动脉介入治疗(PCI)后 30-60 天内新生内膜的显著生长。应用这两种方法的替代模型在逐点误差方面都表现出了很高的准确性,第一种方法在整个评估期间所有输出的误差都更小。针对药物剂量与 ISR 发生率的参数研究提供了关于新生内膜生长的有价值的见解,其中 ISR 发生率对峰值药物通量的非线性依赖性呈现出有趣的周期性模式。应用训练好的模型,可以有效地评估 ISR 的发生率,并确定药物剂量的最佳参数范围。

结论

所展示的非侵入式降阶替代模型被证明是预测 ISR 结果的有力工具。此外,该方法为 PCI 参数的实时模拟和优化奠定了基础。

相似文献

1
Data-driven reduced order surrogate modeling for coronary in-stent restenosis.基于数据驱动的冠状动脉支架内再狭窄降阶代理模型。
Comput Methods Programs Biomed. 2024 Dec;257:108466. doi: 10.1016/j.cmpb.2024.108466. Epub 2024 Oct 25.
2
A physics-informed deep learning framework for modeling of coronary in-stent restenosis.基于物理信息的深度学习框架用于冠状动脉支架内再狭窄建模。
Biomech Model Mechanobiol. 2024 Apr;23(2):615-629. doi: 10.1007/s10237-023-01796-1. Epub 2024 Jan 18.
3
Everolimus-Eluting Stents in Patients With Bare-Metal and Drug-Eluting In-Stent Restenosis: Results From a Patient-Level Pooled Analysis of the RIBS IV and V Trials.依维莫司洗脱支架用于裸金属和药物洗脱支架内再狭窄患者:RIBS IV和V试验患者水平汇总分析结果
Circ Cardiovasc Interv. 2016 Jul;9(7). doi: 10.1161/CIRCINTERVENTIONS.115.003479.
4
A comparison of clinical presentations, angiographic patterns and outcomes of in-stent restenosis between bare metal stents and drug eluting stents.比较裸金属支架和药物洗脱支架的支架内再狭窄的临床表现、血管造影模式和结局。
EuroIntervention. 2010 Feb;5(7):841-6. doi: 10.4244/eijv5i7a141.
5
Characterization of in-stent neointimal tissue components following drug-eluting stent implantation according to the phase of restenosis using a 40-MHz intravascular ultrasound imaging system.使用40兆赫血管内超声成像系统,根据再狭窄阶段对药物洗脱支架植入后支架内新生内膜组织成分进行表征。
J Cardiol. 2014 Dec;64(6):423-9. doi: 10.1016/j.jjcc.2014.03.001. Epub 2014 Apr 29.
6
Drug-Eluting Stent Restenosis: Modern Approach to a Classic Challenge.药物洗脱支架再狭窄:经典挑战的现代应对策略。
Curr Cardiol Rev. 2023;19(3):e030123212355. doi: 10.2174/1573403X19666230103154638.
7
[Analysis of optical coherence tomography of early and very late stent restenosis after drug-eluting stent implantation].[药物洗脱支架植入术后早期及极晚期支架再狭窄的光学相干断层扫描分析]
Zhonghua Yi Xue Za Zhi. 2017 Jun 20;97(23):1778-1783. doi: 10.3760/cma.j.issn.0376-2491.2017.23.005.
8
Effectiveness of everolimus-eluting stents in the treatment of drug-eluting stent versus bare-metal stent restenosis.依维莫司洗脱支架治疗药物洗脱支架与裸金属支架再狭窄的有效性。
Coron Artery Dis. 2012 Nov;23(7):492-6. doi: 10.1097/MCA.0b013e328358a58f.
9
Clinical outcomes of the Resolute zotarolimus-eluting stent in patients with in-stent restenosis: 2-year results from a pooled analysis.药物涂层支架治疗支架内再狭窄患者的临床结果:一项汇总分析的 2 年结果。
JACC Cardiovasc Interv. 2013 Sep;6(9):905-13. doi: 10.1016/j.jcin.2013.04.017. Epub 2013 Aug 14.
10
Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry.药物洗脱支架治疗支架内再狭窄的临床结果:前瞻性多中心德国 DES.DE 注册研究第一阶段的结果。
EuroIntervention. 2011 Jun;7(2):201-8. doi: 10.4244/EIJV7I2A34.